Jinyu Bio-Technology News

Biotech Co., Ltd. (600201): Non-oral products continue to gain strength and profits continue to improve

華創證券May 8 05:16

Biotech Co., Ltd. (600201): Steady growth in the face of adversity, R&D investment reaps rewards

西南證券May 1 11:00

Bio Co., Ltd. (600201): Business quality continues to improve, and new products can be expected to be launched

東興證券Apr 30 05:36

Biotech Co., Ltd. (600201): Improving profitability, R&D investment entering the harvest period

國海證券Apr 28 11:00

Bio Co., Ltd. (600201): Non-foot-and-mouth disease products reinforce product matrix profitability and steady recovery

中金公司Apr 27 00:46

Biotech Co., Ltd. (600201): Strong performance, strong performance, new products blossom, and the leader in animal insurance innovation continues to grow

開源證券Apr 26 11:00

China Galaxy released a research report on April 25 stating that it gave Biotech Co., Ltd. (600201.SH) a recommended rating. The main reasons for the rating include: 1) the company's revenue & profit growth in 23, and steady performance in 24Q1; 2) the gr

Zhitong FinanceApr 26 09:31

Bio Co., Ltd. (600201): Stable performance in 24Q1, gross margin showed an upward trend

銀河證券Apr 25 11:00

Biotech Co., Ltd. (600201): The traditional leading style of animal insurance continues to fully innovate and set sail again

國投證券Mar 21 00:01

Biotech Co., Ltd. (600201): Non-oral products promote a smooth rise in profit centers

開源證券Nov 15, 2023 01:26

Biotech Co., Ltd. (600201): The gross profit level has been significantly repaired, and the annual equity incentive target has been achieved ahead of schedule

興業證券Nov 6, 2023 10:00

Biotech Co., Ltd. (600201) 2023 Third Quarter Report Review: Q3 performance continues to grow, new progress has been made in products under development

國海證券Nov 2, 2023 11:00

Biotech Co., Ltd. (600201): Diversification strategy boosts performance against the trend and increases, major single product layouts can be expected in the future

中信建投證券Oct 31, 2023 05:12

Biotech Co., Ltd. (600201: Non-export product performance is outstanding, optimistic about the company's product diversification potential

華創證券Sep 17, 2023 00:36

Biotech Co., Ltd. (600201) 2023 semi-annual report review: profit levels have been drastically restored, domestic business revenue has increased

興業證券Aug 31, 2023 23:56

Biology Co., Ltd. (600201): Steady management and smooth progress of non-plague vaccine

東興證券Aug 29, 2023 05:42

Biotech Co., Ltd. (600201): Product restructuring combined with cost reduction and efficiency measures to reduce costs and increase efficiency in the first half of the year +28%

國信證券Aug 28, 2023 08:02

Bio Shares (600201): Vaccine sales are steadily improving, and cost investment is dragging down short-term profitability

中金公司Aug 25, 2023 06:52

Biology Co., Ltd. (600201): The non-plague vaccine is progressing smoothly and I am optimistic about the development of the company's multiple products!

天風證券Aug 25, 2023 03:12

Biotech Shares (600201): Revenue structure is becoming more balanced and profitability has improved markedly

浙商證券Aug 25, 2023 02:36